Indeed, while in those systems tumour spread depended on the downregulation of Eph receptors in a cell-autonomous manner, in our GBM model non-cell-autonomous constitutive activation of Eph forward signalling is responsible, suggesting that the mechanisms that evade ephrin repulsion during tumour progression might be critically dependent on cancer type. This evidence concerns the gene EPHA1 and glioblastoma.